New Market Report Now Available: InDex Pharmaceuticals AB -...
The company has developed two products based on its technology platform. Its products include Kappaproct, which is being developed in Phase III clinical trials for the treatment of steroid resistant ulcerative colitis; and DIMS 9054, a preclinical potential treatment for steroid resistant asthma.Full Story
#1 Jun 23, 2013
Nigeria navy recruitment service form is out for more detail call 08146558553. Please don't miss this opportunity.
#2 Jun 23, 2013
Nigeria custom recruitment service is presently going on for more information contact 08146558553.
Add your comments below
|The murine appendiceal microbiome is altered in...||Jul '14||Terry||1|
|New treatment could help those with Crohn's, co... (Oct '13)||Jun '14||question||12|
|Study Finds No Tie Between Acne Drug Accutane a... (Mar '13)||Jan '14||Zonnya||10|
|FDA Approves Uceris (Budesonide) for Patients W... (Jan '13)||Oct '13||Chuck||2|
|Tax benefit, higher sales lift Santarus 2Q prof... (Aug '13)||Aug '13||Brett Steele||1|
|Clinical and radiological characteristics of lu... (Aug '13)||Aug '13||Carmen||1|
|Biomarkers Discovered for Inflammatory Bowel Di... (May '13)||May '13||Vaccine Side effects||1|
Find what you want!
Search Ulcerative Colitis Forum Now